Immunosuppression study helps understand why some prostate cancer treatments do not work as expected
A recent study reveals that immunosuppression, or reduced immune response, in prostate cancer is associated with a specialized epithelial subtype.
A recent study reveals that immunosuppression, or reduced immune response, in prostate cancer is associated with a specialized epithelial subtype.